Original Research
Published on 09 Dec 2022
Determinants of early working impairments in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1062847
- 3,624 views
- 9 citations
Type at least 3 characters
822 articles
Case Report
Published on 08 Dec 2022
Misdiagnosis of Susac syndrome as demyelinating disease and primary angiitis of the central nervous system: A case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1055038
- 3,214 views
Case Report
Published on 02 Dec 2022
Case report: MOG-IgG-associated encephalitis with Epstein-Barr virus infection and Alzheimer's pathologic change in cerebrospinal fluid
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1013413
- 4,527 views
- 4 citations
Case Report
Published on 01 Dec 2022
Neuromyelitis optica spectrum disorders associated with AQP4-positive-cancer—A case series
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1071519
- 3,657 views
- 6 citations
Original Research
Published on 01 Dec 2022
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1018785
- 9,692 views
- 24 citations
Systematic Review
Published on 30 Nov 2022
Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1056411
- 3,743 views
- 3 citations
Editorial
Published on 29 Nov 2022
Editorial: Immune-mediated disorders of the spinal cord: Diagnosis, treatment strategies, and outcomes in the 21st century
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1087631
- 1,856 views
Case Report
Published on 29 Nov 2022
Case report: Varicella-zoster virus infection triggering progressive encephalomyelitis with rigidity and myoclonus
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1042988
- 3,949 views
- 3 citations
Editorial
Published on 22 Nov 2022
Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1093254
- 1,728 views
Original Research
Published on 17 Nov 2022
Ovarian resection in anti-N-methyl-D-aspartate receptor encephalitis: A comparison of surgical approaches
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1043785
- 2,603 views
- 2 citations
Original Research
Published on 15 Nov 2022
Elevated plasma D-dimer levels in patients with anti-N-methyl-D-aspartate receptor encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1022785
- 2,225 views
- 2 citations
Original Research
Published on 14 Nov 2022
Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1034056
- 4,868 views
- 6 citations
Review
Published on 10 Nov 2022
The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1026449
- 7,026 views
- 16 citations
Brief Research Report
Published on 10 Nov 2022
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1032830
- 1,770 views
- 5 citations
Original Research
Published on 09 Nov 2022
Fertility preferences and unmet need for family planning in women with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1035596
- 3,412 views
- 5 citations
Review
Published on 07 Nov 2022
Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1011579
- 20,031 views
- 49 citations